Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 29, 2013	Sep. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 19,028	$ 24,878
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	3,628	2,701
Amortization of intangible assets	1,588	992
Stock-based compensation expense	924	576
Deferred compensation expense	231	175
Reversal of tax valuation allowance	0	(6,650)
Deferred income taxes	3,730	0
Gain on sale of fixed assets & acquisition of business	(424)	(237)
Stock warrants revaluation	0	1,731
Decrease in cash surrender value of life insurance	68	67
Deferred financing amortization	312	439
Amortization of debt discount	0	147
Change in operating assets and liabilities, net of the effects of acquisitions:
Trade receivables	(14,311)	(14,347)
Inventories	(6,819)	(9,861)
Prepaid expenses and other	(914)	(5)
Accounts payable and accrued liabilities	14,704	14,307
Payments on deferred compensation obligations	(293)	(283)
Net cash provided by operating activities	21,452	14,630
CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures	(5,214)	(5,281)
Proceeds from sale of property, equipment and facility	1,009	58
Business acquisitions	(16,544)	(9,223)
Other	(42)	(42)
Net cash used in investing activities	(20,791)	(14,488)
CASH FLOWS FROM FINANCING ACTIVITIES
Long-term debt borrowings (payments), net	13,284	(12)
Payment of deferred financing/debt issuance costs	(100)	(13)
Stock repurchases	(6,078)	0
Realization of excess tax benefit on stock-based compensation	2,363	0
Proceeds from exercise of stock options, including tax benefit	64	221
Other	(118)	0
Net cash provided by financing activities	9,415	196
Increase in cash and cash equivalents	10,076	338
Cash and cash equivalents at beginning of year	434	550
Cash and cash equivalents at end of period	$ 10,510	$ 888